3B Blackbio (3BBLACKBIO) | Stock Overview & Key Data
3B Blackbio Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹2,350.00 on December 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3B Blackbio
3BBLACKBIO
|
11.13B Small-cap | -7.13% | -9.11% | -6.85% | -11.83% | -19.55% | -24.89% | 58.97% | 58.97% | 58.97% | 58.97% | 58.97% |
|
Biocon
BIOCON
|
566.52B Large-cap | -4.57% | 14.38% | 9.01% | 0.60% | 6.37% | 27.63% | 78.42% | 11.37% | 265.74% | 609.92% | 1,204.47% |
|
OneSource Specialty
ONESOURCE
|
202.76B Large-cap | 1.08% | 3.09% | 35.60% | 9.83% | 1.28% | -5.07% | 6.70% | 6.70% | 6.70% | 6.70% | 6.70% |
|
Zota Health Care
ZOTA
|
39.41B Small-cap | 9.32% | -7.75% | 1.36% | -24.28% | -19.38% | 12.58% | 278.03% | 548.16% | 1,137.98% | 1,137.98% | 1,137.98% |
|
Dishman Carbogen
DCAL
|
26.50B Small-cap | -1.29% | 4.71% | 18.97% | -17.56% | -23.92% | -26.89% | 58.94% | -7.70% | 27.01% | 314.26% | 123.54% |
|
Panacea Biotec
PANACEABIO
|
21.84B Small-cap | 4.95% | 16.18% | 35.33% | 23.76% | 14.82% | -22.18% | 242.47% | 5.32% | 298.85% | 175.16% | 35.76% |
Ownership & Short Interest
Calculate Your 3B Blackbio Investment Returns
Long-Term Investment Performance Analysis
3B Blackbio stock price in Jan 2024 was ₹782.55, A ₹1,000.00 lump sum investment in 3B Blackbio made 2 years ago would be worth approximately ₹1,443.68 today, representing a positive return of 44.37%. This translates to an annualized return (CAGR) of 16.50%.
2 Years 4 Months Investment Scenario (Jan 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is 3BBLACKBIO's 52-week high and low?
- In the last 52 weeks, 3B Blackbio reached a high of ₹1,750.00 (on January 19, 2026) and a low of ₹1,083.50 (on June 2, 2026).
- What is the market cap and P/E ratio for 3BBLACKBIO?
- Curious about 3B Blackbio's size and valuation? Its market capitalization stands at 11.13B. When it comes to valuation, the P/E ratio (trailing twelve months) is 20.80, and the forward P/E (looking ahead) is N/A.
- Does 3BBLACKBIO pay dividends? If so, what's the yield?
- As for dividends, 3B Blackbio isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are 3B Blackbio's main competitors or similar companies to consider before investing?
When looking at 3B Blackbio, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON566.52B Healthcare Biotechnology 27.63% 78.42% OneSource Specialty
ONESOURCE202.76B Healthcare Biotechnology -5.07% 6.70% Zota Health Care
ZOTA39.41B Healthcare Biotechnology 12.58% 278.03% Dishman Carbogen
DCAL26.50B Healthcare Biotechnology -26.89% 58.94% Panacea Biotec
PANACEABIO21.84B Healthcare Biotechnology -22.18% 242.47% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for 3B Blackbio Diagnostics Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of 3B Blackbio's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.60%, the Debt to Equity ratio from the most recent quarter is 0.09, and its Gross Profit Margin stands at 72.47%.
- What is the recent revenue and earnings growth for 3BBLACKBIO?
- Looking at 3B Blackbio's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 98.30%, and quarterly earnings saw a YoY growth of 62.10%.
- How much of 3BBLACKBIO stock is held by insiders and institutions?
- Wondering who owns 3B Blackbio stock? Company insiders (like executives and directors) hold about 65.90% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.95%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.